Breaking News Instant updates and real-time market news.

MNTA

Momenta

$13.90

-0.25 (-1.77%)

, SHPG

Shire

$174.84

-0.39 (-0.22%)

08:11
11/29/16
11/29
08:11
11/29/16
08:11

Momenta announces M923 clinical study met primary endpoint

Momenta Pharmaceuticals (MNTA) announced that the confirmatory Phase 3 clinical study of M923, a biosimilar HUMIRA candidate developed in collaboration with Baxalta, now part of Shire (SHPG), in patients with moderate-to-severe chronic plaque psoriasis, met its primary endpoint. The proportion of subjects in the study who achieved the primary endpoint, at least 75% reduction in the Psoriasis Area and Severity Index following 16 weeks of treatment, was equivalent between M923 and HUMIRA. The estimated difference in responders was well within the pre-specified confidence interval, confirming equivalence. Equivalence was also achieved in all secondary efficacy endpoints, including the achievement of PASI-50, PASI-90, proportion achieving clear or near-clear skin, and change from baseline in absolute PASI score. Adverse events were comparable in terms of type, frequency, and severity, and were consistent with the published safety data for HUMIRA.

MNTA

Momenta

$13.90

-0.25 (-1.77%)

SHPG

Shire

$174.84

-0.39 (-0.22%)

  • 03

    Dec

MNTA Momenta
$13.90

-0.25 (-1.77%)

09/02/16
LEER
09/02/16
NO CHANGE
LEER
Outperform
Teva third Copaxone patent invalidated as expected, says Leerink
Leerink analyst Jason Gerberry says Teva (TEVA) suffered a largely expected loss in its Copaxone 40mg patent battle, with the Patent Trial and Appeal Board, or PTAB, ruling a third patent invalid. The analyst believes the company will likely appeal the loss, along with PTAB rulings rendered last week that other Copaxone patents were invalid. Gerberry sees the bull case scenario of Teva securing patent exclusivity of the Copaxone 40mg as unlikely and says a settlement with Momenta (MNTA) and Novartis (NVS) is the most logical course of action to mitigate 2017-2018E EPS risk. He reiterates an Outperform rating on Teva's shares.
09/07/16
MAXM
09/07/16
DOWNGRADE
MAXM
Sell
Momenta downgraded to Sell from Hold at Maxim
10/11/16
LEHM
10/11/16
UPGRADE
Target $19
LEHM
Overweight
Momenta upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Douglas Tsao upgraded Momenta Pharmaceuticals to Overweight after attending the consolidated Copaxone 40mg trial. The analyst sees low risk of Momenta being blocked from the 40mg opportunity past 2018 and views the stock's risk/reward as "compelling" at current levels. Tsao believes there is a "good likelihood" that Sandoz, Momenta's partner, launches Copaxone 40mg at-risk as soon as February 2017 upon FDA approval when the 30-month stay expires. The analyst raised his price target for Momenta shares to $19 from $13.
11/22/16
AGIS
11/22/16
INITIATION
Target $15
AGIS
Hold
Momenta initiated with a Hold at Aegis
Aegis analyst Difei Yang iniatied Momenta with a Hold and a $15 price target.
SHPG Shire
$174.84

-0.39 (-0.22%)

11/01/16
BTIG
11/01/16
NO CHANGE
Target $242
BTIG
Buy
Shire's recent weakness overdone, says BTIG
BTIG analyst Timothy Chiang believes the recent selloff in Shire is overdone and that weakness in the Hematology segment was impacted by the timing of large orders. The analyst maintains his Buy rating and $242 price target on Shire shares.
11/02/16
LEER
11/02/16
NO CHANGE
Target $198
LEER
Outperform
Shire price target lowered to $198 from $234 at Leerink
Following a modest Q3 miss, Leerink analyst Jason Gerberry lowered his price target for Shire to $198 from $234 to reflect a more conservative outlook on key franchises due to out-year competitive pressures. The analyst reiterates an Outperform rating on the stock as he believes concerns around pricing look overdone and shares are attractively valued.
11/09/16
SBSH
11/09/16
NO CHANGE
SBSH
Citi sees Healthcare 'relief rally' after Trump win
Citi analyst Andrew Baum expects a "'relief rally" to drive near-term sector outperformance for names in the Healthcare space given the "inability of the Democrats to attain the Presidency, the House or Congress." Longer term, however, the analyst still sees "significant continued legislative risk" for pharma reimbursement. Baum prefers GlaxoSmithKline (GSK), AstraZeneca (AZN), Shire (SHPG) and Roche (RHHBY) among European majors and Bristol-Myers (BMY) and Eli Lilly (LLY) in the U.S.
11/14/16
JPMS
11/14/16
NO CHANGE
JPMS
JPMorgan says Merrimack could fit as target for Shire
JPMorgan analyst Anupam Rama believes Merrimack Pharmaceuticals (MACK) could fit as a potential target for Shire (SHPG). The $1B deal size would be manageable, Rama tells investors in a research note after Ben Harrington's Betaville blog, citing sources, reported Friday that Shire is among the companies participating in Merrimack's strategic review process. Assuming a 40% premium to the intraday Merrimack share price, the deal would be 1% accretive in 2019 and 2% accretive in 2020, Rama estimates.

TODAY'S FREE FLY STORIES

TRP

TransCanada

$44.50

0.34 (0.77%)

07:36
12/07/16
12/07
07:36
12/07/16
07:36
Hot Stocks
TransCanada to proceed with $655M Saddle West Project »

TransCanada announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROP

Roper Technologies

$183.05

1.41 (0.78%)

07:36
12/07/16
12/07
07:36
12/07/16
07:36
Recommendations
Roper Technologies analyst commentary  »

Roper Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$117.39

0.83 (0.71%)

07:35
12/07/16
12/07
07:35
12/07/16
07:35
Hot Stocks
Celgene announces tnAcity trial data of ABRAXANE to be presented at SABCS »

Celgene announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$67.79

0.09 (0.13%)

07:35
12/07/16
12/07
07:35
12/07/16
07:35
Hot Stocks
Harvest Hill to acquire Nutrament business from Nestle »

Brynwood Partners VII…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$9.45

0.77 (8.87%)

, SBUX

Starbucks

$57.44

-0.06 (-0.10%)

07:35
12/07/16
12/07
07:35
12/07/16
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AMD

AMD

$9.45

0.77 (8.87%)

SBUX

Starbucks

$57.44

-0.06 (-0.10%)

ETE

Energy Transfer Equity

$16.56

0.49 (3.05%)

HPE

HP Enterprise

$23.96

-0.25 (-1.03%)

JBLU

JetBlue

$21.19

0.29 (1.39%)

SWKS

Skyworks

$76.17

1.35 (1.80%)

STLD

Steel Dynamics

$38.86

0.73 (1.91%)

Z

Zillow

$37.40

2.63 (7.56%)

TEX

Terex

$31.09

1.25 (4.19%)

DRI

Darden

$77.25

0.54 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

  • 14

    Dec

  • 20

    Dec

NUS

Nu Skin

$51.56

0.05 (0.10%)

07:34
12/07/16
12/07
07:34
12/07/16
07:34
Earnings
Nu Skin sees FY17 EPS $3.10-$3.25, consensus $3.31 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

SNCR

Synchronoss

$42.59

-6.41 (-13.08%)

, IL

Intralinks

$13.12

1.85 (16.42%)

07:34
12/07/16
12/07
07:34
12/07/16
07:34
Recommendations
Synchronoss, Intralinks analyst commentary  »

Synchronoss deal has…

SNCR

Synchronoss

$42.59

-6.41 (-13.08%)

IL

Intralinks

$13.12

1.85 (16.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

NVTA

Invitae

$6.98

-0.07 (-0.99%)

07:34
12/07/16
12/07
07:34
12/07/16
07:34
Hot Stocks
Invitae announces expansion of its breast cancer STAT panel »

Invitae announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$53.72

0.16 (0.30%)

07:33
12/07/16
12/07
07:33
12/07/16
07:33
Hot Stocks
Mallinckrodt reports results from IV acetaminophen health economic analysis »

Mallinckrodt announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

CTIX

Cellceutix

$1.14

-0.045 (-3.80%)

07:33
12/07/16
12/07
07:33
12/07/16
07:33
Hot Stocks
Cellceutix Phase 2 trial dose escalates in second cohort for Brilacidin »

Cellceutix announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$55.99

0.97 (1.76%)

, SFTBF

SoftBank

$62.00

1.93 (3.21%)

07:33
12/07/16
12/07
07:33
12/07/16
07:33
Recommendations
T-Mobile, SoftBank, Sprint, DISH, AT&T, Verizon analyst commentary  »

T-Mobile price target…

TMUS

T-Mobile

$55.99

0.97 (1.76%)

SFTBF

SoftBank

$62.00

1.93 (3.21%)

S

Sprint

$8.17

0.12 (1.49%)

DISH

DISH

$58.51

1.85 (3.27%)

T

AT&T

$39.35

0.72 (1.86%)

VZ

Verizon

$50.36

0.61 (1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 13

    Dec

  • 04

    Jan

  • 24

    Jan

NUS

Nu Skin

$51.56

0.05 (0.10%)

07:32
12/07/16
12/07
07:32
12/07/16
07:32
Hot Stocks
Nu Skin announces CEO transition plan »

Nu Skin Enterprises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Jan

CAL

Caleres

$33.80

0.28 (0.84%)

07:31
12/07/16
12/07
07:31
12/07/16
07:31
Upgrade
Caleres rating change  »

Caleres upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPGI

S&P Global

$113.57

-0.71 (-0.62%)

, CMCSA

Comcast

$68.70

0.02 (0.03%)

07:31
12/07/16
12/07
07:31
12/07/16
07:31
Conference/Events
UBS to hold a conference »

44th Annual Global Media…

SPGI

S&P Global

$113.57

-0.71 (-0.62%)

CMCSA

Comcast

$68.70

0.02 (0.03%)

AMT

American Tower

$100.85

-1.19 (-1.17%)

HSNI

HSN, Inc.

$35.90

-0.2 (-0.55%)

TGNA

TEGNA

$22.63

0.35 (1.57%)

CNSL

Consolidated Communications

LBTYA

Liberty Global

$29.91

0.36 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

TEVA

Teva

$35.03

-2.01 (-5.43%)

, COG

Cabot Oil & Gas

$23.57

-0.06 (-0.25%)

07:30
12/07/16
12/07
07:30
12/07/16
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

TEVA

Teva

$35.03

-2.01 (-5.43%)

COG

Cabot Oil & Gas

$23.57

-0.06 (-0.25%)

FTK

Flotek

$13.11

-0.47 (-3.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 03

    Apr

07:30
12/07/16
12/07
07:30
12/07/16
07:30
General news
Treasury Market Outlook: bond yields are several ticks lower globally »

Treasury Market Outlook:…

CBS

CBS

$60.97

0.16 (0.26%)

07:29
12/07/16
12/07
07:29
12/07/16
07:29
Recommendations
CBS analyst commentary  »

CBS remains a top pick at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

P

Pandora

$13.78

0.41 (3.07%)

07:29
12/07/16
12/07
07:29
12/07/16
07:29
Recommendations
Pandora analyst commentary  »

Pandora Premium will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNCE

Snyder's-Lance

$36.81

0.23 (0.63%)

, LVS

Las Vegas Sands

$62.47

1.35 (2.21%)

07:29
12/07/16
12/07
07:29
12/07/16
07:29
Conference/Events
Bernstein to hold a summit »

3rd Annual Consumer…

LNCE

Snyder's-Lance

$36.81

0.23 (0.63%)

LVS

Las Vegas Sands

$62.47

1.35 (2.21%)

SAP

SAP

$82.99

-0.14 (-0.17%)

TSN

Tyson Foods

$57.39

0.12 (0.21%)

TUP

Tupperware Brands

$55.46

0.24 (0.43%)

CDXC

ChromaDex

$2.39

0.05 (2.14%)

TVIA

Tvia, Inc.

$1.25

0.1 (8.70%)

HRL

Hormel Foods

$33.31

-0.48 (-1.42%)

RCL

Royal Caribbean

$81.15

0.1 (0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 13

    Dec

  • 09

    Jan

RKDA

Arcadia Biosciences

, SEED

Origin Agritech

$2.50

0.02 (0.81%)

07:28
12/07/16
12/07
07:28
12/07/16
07:28
Conference/Events
UBS to hold a conference »

2016 UBS Agriculture Day…

RKDA

Arcadia Biosciences

SEED

Origin Agritech

$2.50

0.02 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

OSIS

OSI Systems

$76.45

0.51 (0.67%)

, ZIXI

ZixCorp

$4.45

0.03 (0.68%)

07:27
12/07/16
12/07
07:27
12/07/16
07:27
Conference/Events
Imperial Capital to hold a conference »

2016 Security Investor…

OSIS

OSI Systems

$76.45

0.51 (0.67%)

ZIXI

ZixCorp

$4.45

0.03 (0.68%)

APDN

Applied DNA Sciences

$2.25

0.05 (2.27%)

ASCMA

Ascent Capital

$18.00

-0.19 (-1.04%)

BCO

Brink's

$39.95

0.9 (2.30%)

CTRL

Control4

$11.20

0.01 (0.09%)

NSSC

NAPCO Security

$8.15

0.15 (1.88%)

VRNT

Verint

$38.20

0.15 (0.39%)

INVE

Identiv

$2.58

0.11 (4.45%)

QLYS

Qualys

$32.25

-0.25 (-0.77%)

TASR

TASER

$28.19

0.11 (0.39%)

PCTI

PCTEL

$5.06

0.09 (1.81%)

RDWR

Radware

$13.64

0.07 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

CGEN

Compugen

$6.10

0.1 (1.67%)

07:26
12/07/16
12/07
07:26
12/07/16
07:26
Hot Stocks
Compugen discloses cancer immunotherapy program for TIGIT »

Compugen disclosed today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CS

Credit Suisse

$14.69

1.01 (7.38%)

07:25
12/07/16
12/07
07:25
12/07/16
07:25
Conference/Events
Credit Suisse to hold a conference »

2016 Quantitative…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

  • 14

    Dec

EW

Edwards Lifesciences

$83.22

0.73 (0.88%)

07:25
12/07/16
12/07
07:25
12/07/16
07:25
Recommendations
Edwards Lifesciences analyst commentary  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

ARGS

Argos Therapeutics

$4.75

0.05 (1.06%)

07:25
12/07/16
12/07
07:25
12/07/16
07:25
Conference/Events
Argos Therapeutics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.